NAGE vs ARMP
Comparison between Niagen Bioscience Inc (NAGE, Company) and Armata Pharmaceuticals Inc (ARMP, Company).
Both NAGE and ARMP are from the Healthcare sector.
5-Year PerformanceARMP has outperformed NAGE, delivering a return of +10.3% compared to -19.6%
NAGE vs ARMP - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
NAGE vs ARMP - Historical Returns
Returns include dividend reinvestment.
NAGE vs ARMP - Annual Returns (2008 - 2026)
Returns include dividend reinvestment.
| Year | NAGE | ARMP |
|---|---|---|
| 2026 | -44.80% | +14.33% |
| 2025 | +16.06% | +222.22% |
| 2024 | +270.98% | -40.32% |
| 2023 | -15.38% | +194.55% |
| 2022 | -57.14% | -78.88% |
| 2021 | -21.26% | +81.20% |
| 2020 | +11.63% | -8.02% |
| 2019 | +26.39% | -1.30% |
| 2018 | -45.98% | -79.57% |
| 2017 | +70.43% | -79.18% |
| 2016 | -9.56% | -89.27% |
| 2015 | +35.56% | -58.11% |
| 2014 | -37.52% | -63.39% |
| 2013 | +182.79% | +185.71% |
| 2012 | -11.67% | +59.09% |
| 2011 | -59.56% | -57.20% |
| 2010 | +202.22% | N/A |
| 2009 | -62.39% | N/A |
| 2008 | -61.00% | N/A |
NAGE vs ARMP Drawdown Comparison
The maximum drawdown for NAGE was -97.00%, occurring on Aug 3, 2009. Recovery took 3150 trading sessions.
The maximum drawdown for ARMP was -99.98%, occurring on Apr 10, 2025. This drawdown has not yet recovered.
The current NAGE drawdown is -81.59%. The current ARMP drawdown is -99.85%.
| Rank | NAGE | ARMP |
|---|---|---|
| #1 | -97.00% Aug 19, 2008 - Feb 25, 2021 | -99.98% Jul 24, 2013 - Apr 10, 2025 |
| #2 | -93.65% Feb 25, 2021 - Sep 26, 2022 | -78.97% Mar 17, 2011 - Jul 12, 2013 |
| #3 | -25.00% Jul 15, 2008 - Jul 22, 2008 | -5.26% Mar 11, 2011 - Mar 17, 2011 |
| #4 | -22.22% Jul 22, 2008 - Aug 19, 2008 | -2.50% Jul 15, 2013 - Jul 17, 2013 |
| #5 | N/A | -2.22% Jul 18, 2013 - Jul 22, 2013 |
Correlation
Correlation between NAGE and ARMP is -0.13 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks